RISS STAGE I PLASMA CELL MYELOMA
Clinical trials for RISS STAGE I PLASMA CELL MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RISS STAGE I PLASMA CELL MYELOMA trials appear
Sign up with your email to follow new studies for RISS STAGE I PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a fourth drug boost myeloma treatment without transplant?
Disease control Recruiting nowThis study compares a four-drug combination (daratumumab, bortezomib, lenalidomide, and dexamethasone) against a three-drug version (without bortezomib) in people newly diagnosed with multiple myeloma who are not planning an early stem cell transplant. The goal is to see if addin…
Matched conditions: RISS STAGE I PLASMA CELL MYELOMA
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 01, 2026 17:42 UTC
-
Blood samples from 2000 people could unlock early cancer detection
Knowledge-focused Recruiting nowThis study collects blood and tissue samples from 2000 people, some with cancer and some without, to create a reference set for evaluating blood tests that aim to detect multiple cancers early. The goal is to help researchers develop and validate these tests so they can find canc…
Matched conditions: RISS STAGE I PLASMA CELL MYELOMA
Sponsor: Alliance for Clinical Trials in Oncology • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:49 UTC